-
PurposeKnocks down endogenous TACC3 and re-expresses knockdown-proof (RNAi-resistant) GFP-tagged human TACC3.
-
Depositing Lab
-
Depositing OrganizationUniversity of Liverpool
Located in United Kingdom of Great Britain and Northern Ireland -
Citations
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 59356 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
| DNA | 59356-D50 | 50 μg of DNA in Tris buffer | $495 | ||
| DNA | 59356-D100 | 100 μg of DNA in Tris buffer | $585 | ||
Backbone
-
Vector backbonepBrain
-
Backbone manufacturerStephen J Royle
- Backbone size w/o insert (bp) 5438
- Total vector size (bp) 7952
-
Modifications to backboneAddition of N-terminal GFP tag. shRNA to knock down endogenous TACC3.
-
Vector typeMammalian Expression, RNAi
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)XL10 Gold
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameTransforming Acidic Coiled Coil protein 3
-
Alt nameTACC3
-
Alt nameERIC1
-
SpeciesH. sapiens (human)
-
Insert Size (bp)2514
-
MutationSilent mutations in amino acids 30-33 to confer siRNA resistance.
-
GenBank IDNM_006342.2
-
Entrez GeneTACC3 (a.k.a. ERIC-1, ERIC1, Tacc4, maskin)
- Promoter CMV
-
Tag
/ Fusion Protein
- GFP (N terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site XmaI (not destroyed)
- 3′ cloning site XbaI (not destroyed)
- 5′ sequencing primer -
- 3′ sequencing primer -
- (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byshRNA sequence as referenced in Gergely, 2003.
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
DNA (Catalog # 59356-D50)
Purpose
Ready-to-use, high-purity DNA prep. DNA aliquots are suitable for use in mammalian cell transfections and other molecular biology applications.
Delivery
- Amount 50 μg
- Concentration 1 μg/μL
- Pricing $495 USD
- Storage 4 ℃ (short-term) or -20 ℃ (long-term)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Quality Control
Every DNA prep is verified by next-generation sequencing, confirming plasmid identity, sequence integrity, and absence of DNA contaminants. Concentration is confirmed to be within ±2.5% of the stated concentration.
Our production process has been validated to consistently yield endotoxin levels below 1.0 EU/μg. Individual lots are not tested for endotoxin.
DNA (Catalog # 59356-D100)
Purpose
Ready-to-use, high-purity DNA prep. DNA aliquots are suitable for use in mammalian cell transfections and other molecular biology applications.
Delivery
- Amount 100 μg
- Concentration 1 μg/μL
- Pricing $585 USD
- Storage 4 ℃ (short-term) or -20 ℃ (long-term)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Quality Control
Every DNA prep is verified by next-generation sequencing, confirming plasmid identity, sequence integrity, and absence of DNA contaminants. Concentration is confirmed to be within ±2.5% of the stated concentration.
Our production process has been validated to consistently yield endotoxin levels below 1.0 EU/μg. Individual lots are not tested for endotoxin.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pBrain-GFP-TACC3KDP-shTACC3 was a gift from Stephen Royle (Addgene plasmid # 59356 ; http://n2t.net/addgene:59356 ; RRID:Addgene_59356) -
For your References section:
A TACC3/ch-TOG/clathrin complex stabilises kinetochore fibres by inter-microtubule bridging. Booth DG, Hood FE, Prior IA, Royle SJ. EMBO J. 2011 Mar 2;30(5):906-19. doi: 10.1038/emboj.2011.15. Epub 2011 Feb 4. 10.1038/emboj.2011.15 PubMed 21297582